Skip to main content
. 2022 Dec 9:1–10. Online ahead of print. doi: 10.1007/s12519-022-00655-w

Table 1.

Current potential indications for pediatric FMT

Diseases The first author Year Identifier
(PMID)
Design Intervention Numbers References
CDI Khoruts A 2010 20048681 Case report Colonoscopy 1 9
Hamilton MJ 2012 22290405 Case control study Colonoscopy 43 5
Van Nood E 2013 23323867 Case control study Nasoduodenal tube 32 6
Wang J 2015 25798243 Case report Nasal jejunal 1 21
Kronman MP 2015 25162365 Case report Nasogastric tube 10 10
Walia R 2014 25162365 Case report Colonoscopy 2 22
Kahn SA 2012 23211865 Case report Nasogastric tube 1 12
Russell G 2010 20547640 Case report Nasogastric tube 1 8
Hourigan SK 2019 31660343 Case report Colonoscopy 9 23
IBD Karolewska-Bochenek K 2018 29151253 Case report Nasoduodenal tube 10 24
Kunde S 2013 23542823 Case report Enema 10 25
Goyal A 2018 29361092 A prospective trial Endoscopy 20 28
Cho S 2019 30320666 A retrospective trial Colonoscopy 8 29
Moutinho BD 2019 30632438 Case report Colonoscopy 1 30
Shimizu H 2016 27324973 Case report Colonoscopy 1 31
Hourigan SK 2015 26198180 Case report Colonoscopy 8 27
IBS Johnsen PH 2018 29100842 RCT Colonoscopy 90 33
FC Tian H 2016 26751143 A pilot study Nasojejunal tube 24 35
NAFLD Philips CA 2017 27816755 A pilot study Nasoduodenal tube 8 43
ASD Kang DW 2017 28122648 An open-label study Oral and colonoscopy 18 45
Li N 2021 34737978 An open-label study Capsule and colonoscopy 56 46
Chen Y 2022 35105621 RCT Capsule 318 47
Diabetes Leiva-Gea I 2018 30224347 Case-control study Oral 43 52
Solito A 2021 34229463 RCT Oral 101 56

FMT fecal microbiota transplantation, CDI Clostridium difficile infection, IBD inflammatory bowel disease, IBS irritable bowel syndrome, FC functional constipation, NAFLD non-alcoholic fatty liver disease, ASD autism spectrum disorder